The effect of royal jelly on growth and short-chain fatty acid production of probiotic bacteria and activity of bacterial procarcinogenic enzymes in rat faeces

• Autorzy: Haddadin M. S. Y. , Haddadin J. , Benguiar R.
• Języki publikacji: EN

Abstrakty

EN

The present study was done to evaluate the effect of three different royal jelly samples on the kinetic growth of two isolates of lactic bacteria; Lactobacillus acidophilus and Bifi dobacterium bifi dum. The results showed that the addition of royal jelly supported and improved the growth of L. acidophilus and B. bifi dum. The highest count of L. acidophilus was 9.01 (log10 cfu/mL) when 2% (w/v) of the royal jelly sample 3 was added to milk. The highest count of B. bifi dum was 9.07 (log10 cfu/mL) when 5% (w/v) of the royal jelly sample 1 was added to milk. Based on the obtained results, royal jelly showed the capability of prebiotic activity and increasing the activity of L. acidophilus and B. bifi dum. Royal jelly promotes SCFAs productions which are believed to have an antitumor effect. The results showed the presence of signifi cant synbiotic effect of fermented milk and royal jelly on the intestinal microfl ora. This effect is translated by the reduction in the faecal enzyme activities of β-glucuronidase, arylsulphatase, and β-gluconsidase which are involved in colon carcinogenesis.

Słowa kluczowe

EN

royal jelly; growth; short-chain fatty acid; probiotic bacteria; enzyme activity; procarcinogenic enzyme; rat; feces; fecal enzyme; lactic acid bacteria; Lactobacillus acidophilus; Bifidobacterium bifidum

• Wydawca: -
• Czasopismo: Polish Journal of Food and Nutrition Sciences
• Rocznik: 2012
• Tom: 62
• Numer: 4
• Opis fizyczny: p.251-258,fig.,ref.

Twórcy

autor

Haddadin M. S. Y.

• Department of Nutrition and Food Technology, Faculty of Agriculture, University of Jordan, Amman, Jordan

autor

Haddadin J.

autor

Benguiar R.

Bibliografia

• 1. Awaisheh S., In vitro studies of the effect of fermented dairy products containing probiotics and neutraceuticals on different characteristics of normal fl ora. Ph.D. 2003, Thesis, University of Jordan, Amman, Jordan.
• 2. Bernardeau M., Vernoux J.P., Henri-Dubernet S., Guéguen M., Safety assessment of dairy microorganisms: The Lactobacillus genus. Int. J. Food Microbiol., 2008, 126, SI, 278–285.
• 3. Bezkorovainy A., Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr., 2001, 73, S399-S405.
• 4. Bincoletto C., Eberlin S., Figueiredo C.A.V., Luengo M.B., Queiroz M.L., Effects produced by royal jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int. Immunopharmacol., 2005, 5, 679–688.
• 5. Burns A.J., Rowland I.R., Anti-carcinogenicity of probiotics and prebiotics. Curr. Issues Intest. Microbiol., 2000, 1, 13––24.
• 6. Djouzi Z., Andrieux C., Degivry M.-C., Bouley C., Szylit O., The association of yogurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microfl ora in germ-free rats and in human fl ora-associated rats. J. Nutr., 1997, 127, 2260–2266.
• 7. El-Nekeety, A.A., El-Kholy, W., Abbas, N.F., Ebaid, A., Amra, H.A., Abdel-Wahhab, M.A., Effi cacy of royal jelly against the oxidative stress of fumonisin in rats. Toxicon, 2007, 50, 256–269.
• 8. Goldin B.R., Gorbach S.L., The effect of milk and lactobacilli feeding on human intestinal bacteria enzyme activity. Am. J. Clin. Nutr., 1984, 39, 756–761.
• 9. Guarner F., Malagelada J.R., Gut fl ora in health and disease. Lancet, 2003, 361, 512–519.
• 10. Haddadin M.S.Y., Nazer I., Sara’ J.R., Robinson R.K., Effect of honey on the growth and metabolism of two bacterial species of intestinal origin. Pakistan J. Nutr., 2007, 6, 693–697.
• 11. Hinnebusch B.F., Meng S.F., Wu J.T., Archer S.Y., Hodin R.A., The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr., 2002, 132, 1012–1017.
• 12. Hyang M.A., Shin Y.P., Do K.L., Jung R.K., Min K.C., Si W.L., Hyung T.L., Kyung J.K., Nam J.H., Antiobesity and lipid-lowering effects of Bifi dobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis., 2011, 10, 116.
• 13. Inoue S., Koya-Miyata S., Ushio S., Iwaki K., Ikeda M., Kurimoto M., Royal jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage. Exp. Gerontol., 2003, 38, 965–969.
• 14. Kailasapathy K., Chin J., Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifi dobacterium spp. Immunol. Cell Biol., 2000, 78, 80–88.
• 15. Kamakura M., Mitani N., Fukuda T., Fukushima M., Antifatigue effect of fresh royal jelly in mice. J. Nutr. Sci. Vitaminol., 2001, 47, 394–401.
• 16. Kohno K., Okamoto I., Sano O., Arai N., Iwaki K., Ikeda M., Kurimoto M., Royal jelly inhibits the production of proinfl ammatory cytokines by activated macrophages. Biosci. Biotechnol. Biochem., 2004, 68, 138–145.
• 17. Leblank A.D., Perdigon G., Reduction of β-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell, 2005, 29, 15–24.
• 18. Lichtenthaler R., Marx F., Total oxidant scavenging capacities of common European fruit and vegetable juices. J. Agric. Food Chem., 2005, 53, 103–110.
• 19. Liong M.T., Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in vivo evidence. Int. J. Mol. Sci., 2008, 9, 854–863.
• 20. Marsili R.T., Ostapenkoo H., Simmons R.E., Green D.E., High performance liquid chromatography determination of organic acids in dairy products. J. Food Sci., 1981, 46, 52–57.
• 21. Marteau P., Pochart P., Flourie B., Pellier P., Santos L., Desjeux J.F., Rambaud J.C., Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifi dobacterium bifi dum on metabolic activities of the colonic fl ora in humans. Am. J. Clin. Nutr., 1990, 52, 685–688.
• 22. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., Matsumoto K., Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J. Nutr. Biochem., 2002, 13, 80–86.
• 23. Nagai T., Inoue R., Preparation and the functional properties of water extract and alkaline extract of royal jelly. Food Chem., 2004, 84, 181–186.
• 24. Nyman M., Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br. J. Nutr., 2002, 87, S163-S168.
• 25. Okamoto I., Taniguchi Y., Kunikita T., Kohno K., Iwaki K., Ikeda M., Kurimoto M., Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci., 2003, 73, 2029–2045.
• 26. Pan X.D., Chen F.Q., Wu T.X., Tang H.G., Zhao Z.Y., Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J. Zhejiang Univ. Sci. B, 2009a, 10, 258–263.
• 27. Pan X.D., Chen F.Q., Wu T.X., Tang H.G., Zhao Z.Y., The acid, bile tolerance and antimicrobial property of Lactobacillus acidophilus NIT. Food Contr., 2009b, 20, 598–602.
• 28. Perez-Conesa D., Lopez G., Ros G., Fermentation capabilities of bifi dobacteria using nondigestible oligosaccharides, and their viability as probiotics in commercial powder infant formula. J. Food Sci., 2005, 70, M279-M285.
• 29. Pool-Zobel B.L., Neudecker C., Domizlaff I., Schillinger S., Ji U., Rumney C., Moretti M., Vilarini I., Scassellati-Sforzolini R., Rowland I., Lactobacillus- and Bifi dobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer, 1996, 26, 365–380.
• 30. Roberfroid M.B., Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr., 2000, 71, 1682–1687.
• 31. Roberfroid M.B., Prebiotics: preferential substrates for specifi c germs? Am. J. Clin. Nutr., 2001, 73, 407S-415S.
• 32. Rossi M., Corradini C., Amaretti A., Nicolini M., Pompei A., Zanoni S., Matteuzzi D., Fermentation of fructooligosaccharides and inulin by bifi dobacteria: a comparative study of pure and fecal cultures. Appl. Environ. Microbiol., 2005, 71, 6150–6158.
• 33. Saarela M., Mättö J., Mattila-Sandholm T., Safety aspects of Lactobacillus and Bifi dobacterium species originating from human oro-gastrointestinal tract or from probiotic products. Microb. Ecol. Health Dis., 2002a, 14, 234–241.
• 34. Saarela M., Lahteenmaki L., Crittenden R., Salminen S., Mattila- Sandholm, T., Gut bacteria and health foods – the European perspective. Int. J. Food Microbiol., 2002b, 78, SI, 99–117.
• 35. Sanz M.L., Polemis N., Morales V., Coezo N., Drakoularakou A., Gibson G.R., Rastal R.A., In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J. Agric. Food Chem., 2005, 53, 2914–2921.
• 36. Sauerwald N., Polster J., Bengsch E., Niessen L., Vogel R.F., Combined antibacterial and antifungal properties of water-soluble fraction of royal jelly. Adv. Food Sci., 1998, 20, 46–52.
• 37. Saxelin M., Tynkkynen S., Mattila-Sandholm T., De Vos W.M., Probiotic and other functional microbes: from markets to mechanisms. Curr. Opin. Biotechnol., 2005, 16, 204–211.
• 38. Shanahan F., Probiotics and infl ammatory bowel disease: from fads and fantasy to facts and future. Br. J. Nutr., 2002, 88 (Suppl. 1), S5–S9.
• 39. Stocker A., Schramel P., Kettrup A., Bengsch E., Trace and mineral elements in royal jelly and homeostatic effects. J. Trace Elem. Med. Biol., 2005, 19, 183–189.
• 40. Topping D.L., Short chain fatty acids produced by intestinal bacteria. Asia Pac. J. Clin. Nutr., 1996, 5, 15–19.
• 41. Upadhyay N., Moudgal V., Probiotics: A Review. JCOM, 2012, 19, 76–84.
• 42. Verschuren P.M., Functional foods: scientifi c and global perspectives. Br. J. Nutr., 2002, 88, S125-S130.
• 43. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shimohara K., Kanaeda J., Yonekura M., Growth stimulation with honey royal jelly DIII protein of human lymphocytic cell lines in a serum-free medium. Biotechnol. Tech., 1996, 10, 959–962.
• 44. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shimohara K., Kanaeda J., Yonekura M., Stimulation of cell growth in the U-937 human myeloid cell line by honey royal jelly protein. Cytotechnology, 1998, 26, 23–27.
• 45. Wollowski I., Rechkemmer G., Pool-Zobel B.L., Protective role of probiotics and prebiotics in colon cancer Am. J. Clin. Nutr., 2001, 73(suppl), 451S–5S.
• 46. Yang X.Y., Yang D.S., Wei-Zhang, Wang J.M., Li C.Y., Hui Y., Lei K.F., Chen X.F., Shen N.H., Jin L.Q., Wang J.G., 10-Hydroxy- 2-decenoic acid from Royal jelly: A potential medicine for RA. J. Ethnopharmacol., 2010, 128, 314–321.
• 47. Zimmermann A., Liver regeneration: the emergence of new pathways. Med. Sci. Monit., 2002, 8, 3, RA 53–63.